Dipyridamole
Who holds supplier records for Dipyridamole? 8 organisations hold a current record for Dipyridamole: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Spain (1), China (1) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dipyridamole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dipyridamole
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dipyridamole. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AGC PHARMA CHEMICALS EUROPE SLUSpainCEP Company GMP cert on recordActive DMF 13870 · latest filing Nov 1998
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 29020 · latest filing Mar 2015
- COHANCE LIFESCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 29745 · latest filing Sept 2015
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 24441 · latest filing Dec 2010
- QIDONG DONGYUE PHARMACEUTICAL CO., LTD.ChinaCEPActive DMF 34995 · latest filing Aug 2020
- SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLItalyCEP Company GMP cert on recordActive DMF 3209 · latest filing Apr 1978
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 35045 · latest filing Aug 2020
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 20416 · latest filing Apr 2007
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Dipyridamole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2021-019 - Rev 01 Dipyridamole | Aug 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2017-023 - Rev 04 Dipyridamole | May 2026 | — |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2014-148 - Rev 02 Dipyridamole | Feb 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2011-244 - Rev 05 Dipyridamole | Sept 2025 | — |
| SOCIETÀ ITALIANA MEDICINALI SCANDICCI S.I.M.S. S.R.L Reggello | IT | CEP 2004-204 - Rev 04 Dipyridamole | Jan 2025 | Inspected Nov 2024 Italy |
| QIDONG DONGYUE PHARMACEUTICAL CO., LTD. Qidong City | CN | R0-CEP 2020-035 - Rev 00 Dipyridamole | Aug 2022 | — |
| AGC PHARMA CHEMICALS EUROPE S.L.U. Malgrat De Mar | ES | R1-CEP 2000-146 - Rev 04 Dipyridamole | Nov 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Dipyridamole are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- Yabao Pharmaceutical Group Co., Ltd.China · Inactive DMF 28566 · filed Aug 2014
- BOEHRINGER INGELHEIM LABSO CHIMIE FINEInactive DMF 22764 · filed May 2009
- OMNICHEM NVInactive DMF 14886 · filed May 2000
- LISAC SAInactive DMF 7905 · filed Feb 1989
- Spain · Inactive DMF 6317 · filed May 1986
- SHANGHAI NO 6 PHARMACEUTICAL FACTORYInactive DMF 5917 · filed Apr 1985
- Italy · Inactive DMF 4016 · filed Nov 1980
- Belgium · Inactive DMF 3867 · filed Jun 1980
- INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactive DMF 3559 · filed Jul 1979
- Italy · Inactive DMF 3489 · filed Feb 1979
Overview
Dipyridamole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL932).
Chemical identity
- IUPAC name
- 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol
- Canonical SMILES
- C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
- InChIKey
- IZEKFCXSFNUWAM-UHFFFAOYSA-N
- Synonyms
- Attia, B01AC07, Cerebrovase 100, Cerebrovase 25, Dipiridamol, Dipyridamole, Dipyridamole component of aggrenox, Iv persantine, Modaplate, NSC-515776, Ofcram pr, Persantin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Platelet Aggregation Inhibitor
- Physiologic effect
- Decreased Platelet Aggregation
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dipyridamole?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Dipyridamole: AGC PHARMA CHEMICALS EUROPE SLU (Spain), ALIVUS LIFE SCIENCES LTD (India), COHANCE LIFESCIENCES LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), QIDONG DONGYUE PHARMACEUTICAL CO., LTD. (China), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (Italy), SOLARA ACTIVE PHARMA SCIENCES LTD (India) and Orchid Pharma Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dipyridamole Drug Master Files are active?
AGC PHARMA CHEMICALS EUROPE SLU (DMF 13870), ALIVUS LIFE SCIENCES LTD (DMF 29020), COHANCE LIFESCIENCES LTD (DMF 29745), MATRIX PHARMACORP PRIVATE LTD (DMF 24441), QIDONG DONGYUE PHARMACEUTICAL CO., LTD. (DMF 34995), SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (DMF 3209), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 35045) and Orchid Pharma Limited (DMF 20416). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dipyridamole records mean?
10 organisations have only inactive Type II DMFs for Dipyridamole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dipyridamole have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Dipyridamole on the EDQM register, including SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), COHANCE LIFESCIENCES LIMITED Mumbai (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), SOCIETÀ ITALIANA MEDICINALI SCANDICCI S.I.M.S. S.R.L Reggello (IT) and QIDONG DONGYUE PHARMACEUTICAL CO., LTD. Qidong City (CN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dipyridamole supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dipyridamole?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.